Document:

Exhibit
10.38

 

EXHIBIT
D.

PURCHASER
ROYALTY AGREEMENT

AMENDED
NOVEMBER 13, 2019

 

This
is an amendment executed on the date set forth on the signature page hereto, to the Purchaser Royalty Agreement (the “Original
Purchaser Royalty Agreement”) dated June 6, 2019, (the “Original Security Agreement”) by and between NutraLife
BioSciences, Inc., a Florida corporation (“NutraLife”), PhytoChem Technologies, Inc. (“PhytoChem”), a
Florida corporation (NutraLife and PhytoChem are collectively referred to herein as the “Company”), and Kahn Family
Limited PT II (the “Purchaser”). The Company and the Purchaser are referred to herein collectively as the “Parties”,
or individually as a “Party”.

 

NOW
THEREFORE, the Parties hereby amend and replace the Original Purchaser Royalty Agreement in its entirety and replace it with
this agreement (the “Purchaser Royalty Agreement”) in exchange for good and valuable consideration the receipt of
which is hereby acknowledged as follows:

 

RECITALS

 

WHEREAS,
the Company obtained certain rights to commercialize and monetize certain technology and phytoextractor equipment known as
the Ennea Processor (“Ennea” or “Ennea Processor”) pursuant to an agreement by and between Owen J. Morgan
(“Morgan”) and the Company dated February 4, 2019 (the “Morgan Agreement”);

 

WHEREAS,
the Company requires capital to manufacture, purchase, monetize and commercialize the Ennea Processors and the Purchaser purchased
a Convertible Promissory Note (the “Note”) which shall bear interest (the “Interest”) at the rate of 5.75
% per annuum (the “Interest”) in the principal amount of $1,000,000 (“Principal” or the “Principal
Amount”) from June 6, 2019 until the Maturity Date (as defined in the Note);

 

WHEREAS,
the First Four (4) Ennea Processors (“Collateral Processors”) that the Company commercializes pursuant to the
Morgan Agreement shall serve as collateral for the Principal Amount pursuant to the terms of the Note and Security Agreement (the
“Security Agreement”) attached to the Investment Agreement as Exhibits B and C;

 

WHEREAS,
as consideration for the purchase of the Note, the Company shall (i) pay to the Purchaser the Interest as set forth in this
Purchaser Royalty Agreement, (ii) issue 500,000 shares of its Common Stock, $.0001 par value per share (the “Common Shares”)
to the Purchaser, and (iii) grant the Purchaser eight and one-half percent (8.5%) of the revenue generated from the Collateral
Processors (the “Royalty”) while the Principal Amount and any interest is outstanding and five percent (5%) thereafter
on the first two (2) collateral processors as set forth as set forth herein.

 

THEREFORE,
in consideration of the mutual considerations herein, the receipt of which is mutually acknowledged, the parties hereto agree
as follows:

 

ARTICLE
1. RECITALS.

 

ARTICLE
1.1 The above recitals are true and correct and made a part hereof.

 

    	 	 	 

     

    

 

ARTICLE
2. DEFINITIONS.

 

ARTICLE
2.1 The Investment Agreement and all exhibits thereto are referred to herein as the “Ancillary Agreements”.
This Purchaser Royalty Agreement and the Ancillary Agreements shall be referred to collectively as the “Transaction
Documents.”

 

The “Collateral Processors” as used in this Purchaser Royalty Agreement shall mean the
first four Ennea Processors monetized and/or commercialized by the Company directly or indirectly as a result of or pursuant
to the Morgan Agreement.

 

ARTICLE
3. FINANCING.

 

ARTICLE
3.1 On or about June 6, 2019, the Purchaser loaned the gross amount of $1,000,000 to the Company pursuant to the Investment
Agreement and Note, each as amended.

 

ARTICLE
4. SOURCE, AMOUNT, AND TIMING OF ROYALTY PAYMENTS.

 

ARTICLE
4.1 Commencing upon the fiscal quarter in which revenue is derived directly or indirectly from any of the Collateral Processors,
the Company shall pay to the Purchaser non-refundable Royalty Payments consisting of eight and one-half percent (8.5%) of all
“Net Revenue” received by the Company as a result of the commercialization and/or monetization of the Collateral Processors
until such time as the Principal Amount has been paid. At such time as the Principal Amount has been paid to the Purchaser, Purchaser
shall receive non-refundable Royalty Payments consisting of 5.00 % of “Net Revenue” received by the Company as a result
of the commercialization and/or monetization of the first two Collateral Processors resulting from the Morgan Agreement.

 

For
the purposes of this Purchaser Royalty Agreement, “Net Revenue” shall mean the total Gross Receipts less direct and
indirect expenses. Gross Receipts shall mean revenue from tolling fees and processing fees, product sales, extraction services,
licenses, development, commercialization and/or other commercialization and monetization of the Collateral Processors including
the disposition, sale or rental of the Collateral Processors.

 

ARTICLE
4.2 For the avoidance of doubt, Net Revenue shall be calculated in accordance with GAAP. The Company hereby agrees to use
its commercial best efforts to maximize its Gross Revenue during the term of this Purchaser Royalty Agreement and in the event
it commercializes any other phytoextractors similar to the Collateral Processors , it will not commercialize or monetize such
other equipment until the maximum capacity of the Collateral Processors has been reached. “Gross Revenues” shall also
include all settlement amounts, payment, and damages received by Company which result from litigation or disputes related to or
arising from the sale, license, development, commercialization and/or other monetization of the Collateral Processors.

 

ARTICLE
4.3 The Royalty Payments shall be paid by the Company to the Purchaser within fifteen (15) days after the end of the
quarter in which the Company receives payment for any Net Revenue from the Collateral Processors.

 

ARTICLE
5. INFORMATION REQUIRED TO BE SUPPLIED WITH EACH PAYMENT.

 

ARTICLE
5.1 With each Royalty Payment, the Company shall supply to the Purchaser a detailed and reasonably satisfactory
accounting and reconciliation of how the Royalty Payment was calculated. The Company agrees to have an officer certify each
reconciliation and provide a reconciliation each calendar month during the term of this Purchaser Royalty Agreement
regardless of whether any Royalty Payment is due.

 

    	 	 	 

     

    

 

ARTICLE
6. TERM.

 

ARTICLE
6.1 This Purchaser Royalty Agreement shall continue for a period of ten (10) years.

 

ARTICLE
7. NO SALE OR ASSIGNMENT BY COMPANY.

 

ARTICLE
7.1 During the term of this Purchaser Royalty Agreement, the Company may not (i) sell (other than ordinary course sales to
customers), assign, or otherwise transfer or encumber the Collateral Processors , (ii) assign or otherwise transfer or encumber
this Purchaser Royalty Agreement, or (iii) create an obligation whereby the Company is required to pay all or a portion of the
revenues derived from the Collateral Processors to any party in priority to the Purchaser and/or Pledgor or the Pledgor, without
first obtaining the prior written consent of the Purchaser.

 

ARTICLE
8. NOTICES.

 

ARTICLE
8.1 Any notice required or permitted by this Purchaser Royalty Agreement shall be in writing and shall be deemed sufficient
upon receipt, when delivered personally or by courier, overnight delivery service or confirmed facsimile, or 48 hours after being
deposited in the U.S. mail as certified or registered mail with postage prepaid, if such notice is addressed to the party to be
notified at such party’s address or facsimile number as set forth on the signature page hereto or as subsequently modified
by written notice.

 

ARTICLE
9. ASSIGNMENT BY PURCHASER.

 

ARTICLE
9.1 Purchaser may not assign a portion or all of its interest in this Purchaser Royalty Agreement to an assignee.

 

ARTICLE
10. EXTRAORDINARY EVENT.

 

ARTICLE
10.1 The Company agrees not to enter into a merger, recapitalization, sale or change of control of the Company or sale transaction
involving all or substantially all of the Company’s equity or assets unless the acquiring or successor entity agrees in
writing to recognize the Purchaser’s rights under this Purchaser Royalty Agreement.

 

ARTICLE
11. APPLICABLE LAW, VENUE, JURISDICTION.

 

ARTICLE
11.1 WAIVER OF CONFLICTS. The Company and the Purchaser each acknowledge that the Pledgor, Brenda Hamilton and her law firm,
Hamilton & Associates Law Group, P.A has in the past performed, and may continue to perform, legal and/or consulting services
for the Company in connection with the Transaction Documents and the matters and transactions described in this Investment Agreement
as well as in matters unrelated to the Transaction Documents. Accordingly, the Company and Purchaser each hereby acknowledges
that they have been advised by Brenda Hamilton & Hamilton & Associates Law Group, P.A. to seek the advice of independent
legal counsel in connection with the Transaction Documents including with respect to the Pledge Agreement, Mortgage and Pledgor
Royal Agreement in which Brenda Hamilton is a Party and the transactions contemplated thereby. Additionally, the Company and Purchaser
each acknowledge that they have had an opportunity to ask for information relevant to this disclosure and has consulted with independent
legal counsel or has had the opportunity to do so and gives its informed consent to Brenda Hamilton & Hamilton & Associates
Law Group, P.A. representation of and/or performance of services for the Company in the connection with the Transaction Documents
and transactions contemplated thereby.

 

    	 	 	 

     

    

 

ARTICLE
11.2 GOVERNING LAW AND JURISDICTION. This Purchaser Royalty Agreement shall be governed by and construed in accordance with
the laws of the State of Florida without regard to principles of conflict law applicable to contracts made and to be performed
with such state. Each of the parties hereto accepts for itself to the jurisdiction of Palm Beach County Florida and irrevocably
consents to such jurisdiction in any proceedings, and waives any objection to venue laid therein. Any controversy or claim arising
out of or relating of this Purchaser Royalty Agreement shall be settled by binding arbitration administered by the American Arbitration
Association and judgment on the award entered in any court having jurisdiction. The arbitration proceedings shall be conducted
before a panel of three neutral arbitrators in Palm Beach County, Florida all of whom shall be members of the bar of the state
of Florida, actively engaged in the practice of law for at least ten (10) years. Either Party hereto may apply to the arbitrator
seeking injunctive relief until the arbitration award is rendered or the controversy otherwise resolved. Either Party may, without
waiving any remedy under this Purchaser Royalty Agreement, seek from any court having jurisdiction any interim or provisional
relief that is necessary to protect the rights or property of that party, pending the arbitral tribunal’s determination
of the merits of the controversy. Each party shall bear its own costs, expenses and attorney fees and an equal share of the arbitrators’
and administrative fees of arbitration. Except as may be required by law, neither a party nor an arbitrator may disclose the existence
content or results of any arbitration hereunder without the prior written consent of the Parties. All documents, testimony and
records shall be received, heard and maintained by the arbitrators in secrecy, available for the inspection only of the Parties
to this Purchaser Royalty Agreement and their respective attorneys and their respective experts who shall agree in advance and
in writing to receive all such information confidentially and to maintain such information in secrecy until such information shall
become generally known. In consideration for and as a material condition of this Purchaser Royalty Agreement, each Party agrees
that final and binding arbitration is the exclusive means for resolving any claim or controversy arising out of or related to
this Purchaser Royalty Agreement. This Agreement is a waiver of all rights the Parties may have to a civil court action. Accordingly,
only an arbitrator, not a judge or jury, will decide the dispute, although the arbitrator has the authority to award any type
of relief that could otherwise be awarded by a judge or jury.

 

[SIGNATURE
PAGE TO FOLLOW]

 

    	 	 	 

     

    

 

IN
WITNESS WHEREOF, the Parties hereto have executed this Purchaser Royalty Agreement on November 13, 2019.

 

	NUTRALIFE
    BIOSCIENCES, INC.	 	KAHN
    FAMILY LIMITED PT II
	 	 	 	 	 
	By:	 	 	By:
    	 
	 	Edgar
    Ward, Chief Executive Officer	 	 	(Signature)
	 	 	 	 	 
	 	 	 	 	 
	PHYTOCHEM
    TECHNOLOGIES, INC.	 	 	(Print
Name)
	 	 	 	 
	 	 	 	 	 
	By:	 	 	 	(Print
    Title)
	 	Edgar
    Ward, Chief Executive Officer	 	 	 
	 	 	 	 	 
	 	Address
    for Notice:	 	Address
    for Notice:
	 	 	 	 
	 	NutraLife
    Biosciences, Inc.	 	 	 
	 	Attn:
    Edgar Ward, Chief Executive Officer	 	 	 
	 	6601
    Lyons Rd. L-6	 	 	 
	 	Coconut
    Creek, Fl. 33073	 	Phone :	 
	 	edgar@NutraFuels.com	 	Email:Exhibit
10.39

 

EXHIBIT
E:

PLEDGE AGREEMENT

AMENDED
NOVEMBER 13, 2019

 

This
is an amendment to that pledge agreement (the “Original Pledge Agreement”) made and effective on June 6, 2019, by
and between NutraLife BioSciences, Inc., a Florida corporation (“NutraLife”), PhytoChem Technologies, Inc. (“PhytoChem”),
a Florida corporation (NutraLife and PhytoChem are collectively referred to herein as the “Company”), Brenda Hamilton,
an individual (the “Pledgor”) and Kahn Family Limited PT II (the “Purchaser”) and is effective as of the
day set forth on the signature page hereto. The Company, the Pledgor and the Purchaser are referred to herein collectively as
the “Parties”, or individually as a “Party”.

 

NOW
THEREFORE, the Parties hereby amend and replace the Original Pledge Agreement in its entirety and replace it with this agreement
(the “Pledge Agreement”) in exchange for good and valuable consideration the receipt of which is hereby acknowledged
as follows:

 

RECITALS:

 

WHEREAS,
the Company obtained certain rights to commercialize and monetize certain technology and phytoextractor equipment known as
the Ennea Processor (“Ennea” or “Ennea Processor”) pursuant to an agreement by and between Owen J. Morgan
(“Morgan”) and the Company dated February 4, 2019 (the “Morgan Agreement”);

 

WHEREAS,
the Company requires capital to manufacture, purchase, monetize and commercialize the Ennea Processors and the Purchaser purchased
a Convertible Promissory Note, as amended (the “Note”) from the Company which bears interest (the “Interest”)
at the rate set forth in the Note (the “Interest”) on the principal amount of $1,000,000 (“Principal”
or the “Principal Amount”);

 

WHEREAS,
the first four of the Ennea Processors that the Company commercializes and/or monetizes pursuant to the Morgan Agreement shall
serve as collateral (“Collateral Processors”) for the Principal Amount pursuant to the terms of the Note and Security
Agreement (the “Security Agreement”) attached to the Investment Agreement as Exhibits B and C;

 

WHEREAS,
in addition to the Company’s Assets, Collateral Processors, Interest (the “Collateral”) and Securities paid
by the Company to the Purchaser as consideration for the Note, the Purchaser requested additional security (the “Additional
Collateral”) for the Principal Amount in the form of a mortgage on real property held by Pledgor which Pledgor has agreed
to provide based upon the representations of the Company and Purchase contained in the Transaction Documents (as defined herein);

 

WHEREAS,
the Pledgor agreed to provide a mortgage lien covering certain real property (the “Real Property”) as set forth
in the mortgage (the “Mortgage”) attached as Exhibit F to the Investment Agreement as the Additional Collateral. In
exchange for providing the Additional Collateral, the Company shall pay to the Pledgor the consideration set forth in this Pledge
Agreement and in the Pledgor Royalty Agreement attached as Exhibit G to the Investment Agreement; and

 

WHEREAS,
the Mortgage will be reduced by all consideration paid to the Purchaser by the Company under the Transaction Documents.

 

    	 

    	 

    

 

NOW
THERFORE, in consideration of the mutual promises contained herein and other good and valuable consideration, receipt of which
is hereby acknowledged, the parties to this Pledge Agreement agree as follows:

 

ARTICLE
1. RECITALS.

 

ARTICLE
1.1 The above recitals are true and correct and made a part hereof.

 

ARTICLE
2. DEFINITIONS.

 

ARTICLE
2.1 The Investment Agreement, Note, Purchaser Royalty Agreement, Security Agreement, Pledgor Royalty Agreement and the Mortgage
are referred to as the “Ancillary Agreements”. This Pledge Agreement and the Ancillary Agreements shall be referred
to collectively as the “Transaction Documents”.

 

ARTICLE
3. REPRESENTATIONS OF THE COMPANY.

 

ARTICLE
3.1 To induce Pledgor to enter into this Pledge Agreement and the Mortgage, the Company and Purchaser hereby represent and
warrant to the Pledgor that each the Company and Pledgor will timely comply with all requirements and obligations under the Transaction
Documents and the Company shall pay all amounts owing to the Purchaser, whether for Royalty Payments, Principal, Interest, Fees,
Expenses, Premiums, Indemnities or otherwise, and that it will delivery full and timely payment of all and any amounts due and/or
which may become due to the Purchaser from the Company from time to time in connection with the Transaction Documents without
limitation. Purchaser understands that all consideration delivered to the Purchaser by the Company pursuant to the Transaction
Documents will be applied to reduce the Principal Amount secured by the Mortgage and as a result, the Mortgage will be reduced
by any and all payments of consideration of any type (including cash or Securities) made by the Company to the Purchaser under
(i) the Transaction Documents and (ii) the Original Investment Agreement and Original Note each dated June 6, 2019.

 

ARTICLE
4. PLEDGE AND CONSIDERATION TO PLEDGOR

 

ARTICLE
4.1 REAL PROPERTY. Based upon the representations of the Company and the Purchaser that they will perform and comply with
their obligations and duties under the Transaction Documents, the Pledgor shall provide the Purchaser with the Mortgage which
shall secure the Company’s payment of the Principal Amount pursuant to the Transaction Documents. The Principal Amount is
secured by the real property located at 1576 Fan Palm Road Boca Raton, Florida (“Real Property Collateral”) as set
forth in the Mortgage. The Mortgage will be reduced from time to time by any and all payments of any nature (including cash or
Securities) made by the Company to the Purchaser under the Transaction Documents.

 

ARTICLE
4.2 CONSIDERATION FOR PLEDGE. In exchange for providing the Real Property Collateral, the Company shall pay to Pledgor: (i)
500,000 shares of the Company’s common stock, $.0001 par value per share (the “Common Shares”) which was issued
upon execution of the Original Pledge agreement, (ii) commencing on December 7, 2019 and ending on the Maturity Date, monthly
payments equal to 5% interest on the Principal Amount accruing on the Principal Amount and accrued interest from June 6, 2019
until the Maturity Date, and (iii) eight and one-half percent (8.5%) of the revenue generated from the Collateral Processors (the
“Royalty”) so long as any portion of the Principal Amount is outstanding and five percent (5%) thereafter on the first
two (2) machines commercialized and/or monetized by the Company as set forth in the Pledgor Royalty Agreement (the “Pledgor
Royalty Agreement”) attached to the Investment Agreement as Exhibit G.

 

    	 

    	 

    

 

ARTICLE
4.3 ISSUANCE OF THE SECURITIES. The Common Shares issued to Pledgor pursuant to Article 4 hereof upon issuance were duly authorized,
validly issued, fully paid and nonassessable, free and clear of all rights, liens and encumbrances.

 

ARTICLE
4.4 FULL RECOURSE NOTE. The Note granted by the Company to the Purchaser is a full recourse promissory note and in the event
of a default by the Company of the Note, the Purchaser shall have full recourse to all the assets of the Company. In the event
of a default by the Company, the Purchaser must first proceed against and exhaust all remedies against the Company and its assets
prior to proceeding against the Mortgage and/or commencing an action to foreclose the Mortgage to recover the difference between
the then outstanding Principal Amount and any and all consideration of any nature paid by the Company to the Purchaser under the
Transaction Documents.

 

ARTICLE
4.5 EXTENSION AND TERMINATION. The terms set forth in the Transaction Documents including may not be extended by the Purchaser
and the Company without the express written consent of the Pledgor so long as any portion of the Principal Amount is outstanding.
In the event that any of the Transaction Documents are amended and/or modified in any respect without the Pledgor’s written
consent while any portion of the Principal Amount is outstanding then (i) Pledgor’s obligation to provide security under
this Pledge Agreement shall automatically cease, (ii) the Mortgage shall be deemed satisfied and released in full as security
for the Principal Amount of the Note and (iii) the Purchaser will immediately record with the Palm Beach County Property Appraiser’s
Officer, a Satisfaction of the Mortgage releasing the Purchaser’s lien on the Real Property at the cost of the Company.

 

ARTICLE
5. THE NOTE & COLLATERAL PROCESSORS.

 

ARTICLE
5.1 COLLATERAL AS SECURITY. A condition precedent to the execution of this Pledge Agreement by the Pledgor is that the Principal
Amount be first secured by the Company’s current and future assets as set forth in the Transaction Documents. The payment
of the Principal Amount by the Company to the Purchaser is a direct debt obligation of the Company and is secured by all current
and future assets of the Company. The Transaction Documents will not be amended, and the Collateral as defined in the Security
Agreement shall not be modified or released without the express written consent of the Pledgor. The Company will not sell or offer
to sell or otherwise transfer or grant or allow the imposition of a lien or security interest upon the Collateral as defined in
the Security Agreement or use any portion thereof in any manner inconsistent with the Transaction Documents or with the terms
and conditions of any policy of insurance thereon. The Company will not sell or offer to sell or otherwise transfer or grant or
allow the imposition of a lien or security interest upon the Collateral or any of its other assets while the Principal is outstanding
or use any portion thereof in any manner inconsistent with this Pledge Agreement or with the terms and conditions of any policy
of insurance thereon. In the event that the Transaction Documents are amended or modified by the Company and Purchaser without
Pledgor’s written consent, the Mortgage shall be deemed satisfied and released in full as security for the Principal Amount
of the Note and the Purchaser will immediately record with the Palm Beach County Property Appraiser’s Officer, a Satisfaction
of the Mortgage releasing the Purchaser’s lien on the Real Property.

 

    	 

    	 

    

 

ARTICLE
6. COVENANTS.

 

ARTICLE
6.1 The Company agrees to indemnify, defend and hold harmless Pledgor against all losses, claims, demands, liabilities and
expenses of every kind caused by Pledgor’s entry into this Pledge Agreement and the Mortgage including attorneys fees. The
Company further agrees that while the Mortgage is outstanding not to permit any lien on its assets and that the Company not to
sell, hypothecate or otherwise dispose of, nor permit the transfer by operation of law of, any of its assets until such time as
the Purchaser has recorded with the Palm Beach County Property Appraiser’s Officer, a Satisfaction of the Mortgage releasing
the Mortgage on the Real Property.

 

ARTICLE
7. CONVERSION OF PRINCIPAL AMOUNT BY PURCHASER.

 

ARTICLE
7.1 Under the terms of the Note, the Purchaser may at any time while the Note is outstanding, convert the amount of
outstanding Principal and accrued Interest due under the Note into the Company’s Common Stock, $.0001 par value per
share (the “Conversion Shares”) at the price of $1.00 per share. Should the Purchaser exercise its right to
convert the Note into the Conversion Shares then the Real Property Collateral shall be released as security for the Principal
Amount and the Purchaser will record with the Palm Beach County Property Appraiser’s Officer, a Satisfaction of the
Mortgage releasing the Purchaser’s lien on the Real Property.

 

ARTICLE
8. DEFAULT OF THE NOTE.

 

ARTICLE
8.1. DEFAULT. A “Default” shall mean that the Company has failed to make any payment required under the Note,
within fifteen (15) days after the date the payment is due.

 

ARTICLE
8.2 PRIORITY. If after the exhaustion of all other remedies including enforcement of the lien against the Collateral and collection
of all amounts due from the Company, there remains a Default owed to Purchaser, then the Purchaser shall provide written notice
to Pledgor of the default (“Notice of Default”) and Pledgor shall have the option but not the obligation to cure the
Default. In such event, the amounts paid by Pledgor to enforce its rights hereunder shall bear interest at the highest rate allowed
under Florida law.

 

ARTICLE
8.3 INTEREST IN THE EVENT OF DEFAULT. So long as the Company is in default of its obligations under the Transaction Documents,
then the Company shall pay Pledgor interest on the Principal and accrued interest outstanding under the Note at the highest rate
allowed under Florida law.

 

ARTICLE
8.4 PLEDGOR’S LIABILITY. Under no circumstances shall the Mortgage secure more than the
Principal Amount minus all consideration of any nature paid by the Company to the Purchaser under the Transaction Documents.

 

ARTICLE
8.5 COLLECTION. If the Company defaults on its obligations under the Note, this Pledge Agreement or any of the other Transaction
Documents, the Company shall reimburse Pledgor on demand for (i) payments made by Pledgor to Purchaser to cure a Default by the
Company under the Investment Agreement and/or Note, and (ii) all costs and expenses, including attorneys’ fees and disbursements
that Pledgor incurs in exercising any right, power, or remedy provided by this Pledge Agreement, the Ancillary Documents or by
law or defending any action arising out of this Pledge Agreement or the Ancillary Documents. Additionally, in the event of a Default
by the Company, all costs incurred and paid by Pledgor including but not limited to attorney fees and any amounts Pledgor pays
to cure a Default by the Company of the Note will bear interest at the highest rate allowed under Florida law.

 

    	 

    	 

    

 

ARTICLE
9. RELEASE OF COLLATERAL UPON SATISFACTION OF NOTE.

 

ARTICLE
9.1 Simultaneously with the Purchaser’s receipt of consideration from the Company from time to time in any form (including
Securities, Interest or Royalties as defined in the Investment Agreement) with an aggregate value equal to the Principal Amount
pursuant to the Transaction Documents, the Purchase will record with the Palm Beach County Property Appraiser’s Officer,
a Satisfaction of the Mortgage signed by the Purchaser releasing the Purchaser’s lien on the Real Property. All costs associated
with the Mortgage including recording fees and taxes shall be paid by the Company.

 

ARTICLE
10. WAIVER OF CONFLICTS.

 

ARTICLE
10.1 The Company and the Purchaser each acknowledge that the Pledgor, Brenda Hamilton and her law firm, Hamilton & Associates
Law Group, P.A has in the past performed, and may continue to perform, legal and/or consulting services for the Company in connection
with the Transaction Documents and the matters and transactions described therein as well as in matters unrelated to the Transaction
Documents. Accordingly, the Company and Purchaser each hereby acknowledge that they have been advised by Brenda Hamilton &
Hamilton & Associates Law Group, P.A. to seek the advice of independent legal counsel in connection with the Transaction Documents
and transactions contemplated thereby including the Pledge Agreement, Mortgage and Pledgor Royalty Agreement in which Brenda Hamilton
is a Party. Additionally, the Company and Purchaser each acknowledge that they have had an opportunity to ask for information
relevant to this disclosure and has consulted with independent legal counsel or has had the opportunity to do so and gives its
informed consent to Brenda Hamilton & Hamilton & Associates Law Group, P.A. representation of and/or performance of services
for the Company in the connection with the Transaction Documents and transactions contemplated thereby.

 

11.
MISCELLANEOUS.

 

ARTICLE
11.1 NOTICES. Any and all notices or other communications or deliveries to be provided by the parties shall be delivered by
facsimile, sent by a nationally recognized overnight courier service, addressed to the Company, at the addresses set forth on
the signature page hereto or such other address or facsimile number as the Company may specify for such purposes by notice to
the Purchaser delivered in accordance with this Article.

 

ARTICLE
11.2 ABSOLUTE OBLIGATION. Except as expressly provided herein, no provision of this Pledge Agreement shall alter or impair
the obligation of the Company to pay all amounts due to Purchaser and Pledgor, which are absolute and unconditional. The Note
is a direct debt obligation of the Company secured by the Collateral (as defined in the Note).

 

    	 

    	 

    

 

ARTICLE
11.3 GOVERNING LAW AND JURISDICTION. This Pledge Agreement shall be governed by and construed in accordance with the laws
of the State of Florida without regard to principles of conflict law applicable to contracts made and to be performed with such
state. Each of the parties hereto accepts for itself to the jurisdiction of Palm Beach County Florida and irrevocably consents
to such jurisdiction in any proceedings and waives any objection to venue laid therein. Any controversy or claim arising out of
or relating of this Pledge Agreement shall be settled by binding arbitration administered by the American Arbitration Association
and judgment on the award entered in any court having jurisdiction. The arbitration proceedings shall be conducted before a panel
of three neutral arbitrators in Palm Beach County, Florida all of whom shall be members of the bar of the state of Florida, actively
engaged in the practice of law for at least ten (10) years. Either Party hereto may apply to the arbitrator seeking injunctive
relief until the arbitration award is rendered or the controversy otherwise resolved. Either Party may, without waiving any remedy
under this Pledge Agreement, seek from any court having jurisdiction any interim or provisional relief that is necessary to protect
the rights or property of that party, pending the arbitral tribunal’s determination of the merits of the controversy. Each
party shall bear its own costs, expenses and attorney fees and an equal share of the arbitrators’ and administrative fees
of arbitration. Except as may be required by law, neither a party nor an arbitrator may disclose the existence content or results
of any arbitration hereunder without the prior written consent of the Parties. All documents, testimony and records shall be received,
heard and maintained by the arbitrators in secrecy, available for the inspection only of the Parties to this Pledge Agreement
and their respective attorneys and their respective experts who shall agree in advance and in writing to receive all such information
confidentially and to maintain such information in secrecy until such information shall become generally known. In consideration
for and as a material condition of this Pledge Agreement, each Party agrees that final and binding arbitration is the exclusive
means for resolving any claim or controversy arising out of or related to this Pledge Agreement. This Pledge Agreement is a waiver
of all rights the Parties may have to a civil court action. Accordingly, only an arbitrator, not a judge or jury, will decide
the dispute, although the arbitrator has the authority to award any type of relief that could otherwise be awarded by a judge
or jury.

 

ARTICLE
11.4 SENIORITY. The Company agrees that it shall not incur any indebtedness senior to the Note while it remains outstanding
and shall not encumber the Collateral (as defined in the Note) with any interest senior to the Note. If action is instituted to
collect on the Note, the Company shall all pay all costs and expenses of Pledgor related thereto, including attorney’s fees,
incurred in connection with such action.

 

ARTICLE
11.5 BANKRUPTCY. The Company’s obligations hereunder shall not be influenced, affected or diminished by any composition
of debts, winding up, bankruptcy, as the case may be, of the Company, including any scheme or arrangement approved by any court
or other compromise or arrangement made by the Company. The Company undertakes not to claim in such cases in competition with
the Purchaser or Pledgor and not to claim from the Pledgor or Purchaser any amount received by the Pledgor or Purchaser in this
way or in any other way for any reason whatsoever. The Company shall not claim any debt or payment or enter proof thereof in any
Bankruptcy or winding- up proceedings or in any other arrangement or compromise with respect to the Company, until such time as
the Pledgor and Purchaser shall receive in full all the amounts due or which may become due to the Purchaser and/or Pledgor from
the Company as a result of the Ancillary Agreements or this Pledge Agreement.

 

ARTICLE
11.6 SEVERABILITY. If any provision of this Pledge Agreement is invalid, illegal or unenforceable, the balance of this
Pledge Agreement shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall
nevertheless remain applicable to all other Persons and circumstances. If it shall be found that any interest or other amount
deemed interest due hereunder violates applicable laws governing usury, the applicable rate of interest due hereunder shall
automatically be lowered to equal the maximum permitted rate of interest. The Company covenants (to the extent that it may
lawfully do so) that it shall not at any time insist upon, plead, or in any manner whatsoever claim or take the benefit or
advantage of, any stay, extension or usury law or other law which would prohibit or forgive the Company from paying all or
any portion of the principal of or interest on the Note as contemplated herein, wherever enacted, now or at any time
hereafter in force, or which may affect the covenants or the performance of the Note, and the Company (to the extent it may
lawfully do so) hereby expressly waives all benefits or advantage of any such law, and covenants that it will not, by resort
to any such law, hinder, delay or impede the execution of any power herein granted to the Purchaser or Pledgor.

 

    	 

    	 

    

 

ARTCLE
11.7 HEADINGS. The headings contained herein are for convenience only, do not constitute a part of this Pledge Agreement and
shall not be deemed to limit or affect any of the provisions hereof.

 

ARTICLE
11.8 PAYMENT. All payments by the Company shall be made in lawful money of the United States of America at such place as the
Pledgor hereof may from time to time designate in writing to the Company.

 

IN
WITNESS WHEREOF, the Parties hereto have executed this Pledge Agreement on November 13, 2019.

 

	NUTRALIFE
    BIOSCIENCES, INC.	 	KAHN FAMILY LIMITED PT II
	 	 	 	 	 
	By:  	                                    	 	By:	                                     
	 	Edgar
    Ward, Chief Executive Officer	 	 	(Signature)
	 	 	 	 	 
	 	 		 
	PHYTOCHEM
TECHNOLOGIES, INC.	 	 	(Print
Name)
	 	 	 	 	 
	By:	 	 		  
	 	Edgar
    Ward, Chief Executive Officer	 	 	(Print
    Title)
	 	 	 	 	 
	Address
    for Notice:	 	Address for Notice:
	 	 	 
	NutraLife
    Biosciences, Inc.	 	 	 
	Attn:
        Edgar Ward, Chief Executive Officer

        
	 	 	 
	6601
        Lyons Rd. L-6	 	 	 
	Coconut
        Creek, Fl. 33073

        
	 	Phone:  	
	edgar@NutraFuels.com	 	Email:	 

 

	By: 	                                     	 	 
	 	Brenda
    Hamilton, an individual as Pledgor	 	 

 

	Address
    for Notice:	 	 
	 	 	 
	1576 Fan Palm Road

                                                         Boca Raton Fl 33432

                                                         561-271-8417
	 	 
	bhamilton@securitieslawyer101.com

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}]]